Literature DB >> 21938271

Use of oral isotretinoin in the management of rosacea.

Hyunhee Park1, James Q Del Rosso.   

Abstract

Rosacea is a chronic inflammatory disease affecting roughly 16 million Americans. Topical and oral antibiotic/anti-inflammatory agents are currently the mainstay of therapy and are often used in combination. In this article, the authors discuss the use of oral isotretinoin in the management of rosacea, exploring dosage, comparable efficacy, safety, and cost.

Entities:  

Year:  2011        PMID: 21938271      PMCID: PMC3175801     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  73 in total

1.  Effect of oral isotretinoin on dysplastic nevi.

Authors:  L Edwards; F Meyskens; N Levine
Journal:  J Am Acad Dermatol       Date:  1989-02       Impact factor: 11.527

2.  Oral retinoids in mycosis fungoides and Sézary syndrome: a comparison of isotretinoin and etretinate. A study from the Scandinavian Mycosis Fungoides Group.

Authors:  L Molin; K Thomsen; G Volden; A Aronsson; H Hammar; L Hellbe; G L Wantzin; G Roupe
Journal:  Acta Derm Venereol       Date:  1987       Impact factor: 4.437

3.  Resolution of disseminated granuloma annulare following isotretinoin therapy.

Authors:  S M Schleicher; H J Milstein
Journal:  Cutis       Date:  1985-08

4.  Isotretinoin-PUVA for psoriasis.

Authors:  H Hönigsmann; K Wolff
Journal:  Lancet       Date:  1983-01-29       Impact factor: 79.321

5.  Response of rosacea to isotretinoin.

Authors:  J R Marsden; S Shuster; M Neugebauer
Journal:  Clin Exp Dermatol       Date:  1984-09       Impact factor: 3.470

6.  Treatment of rosacea by metronidazole.

Authors:  R J Pye; J L Burton
Journal:  Lancet       Date:  1976-06-05       Impact factor: 79.321

7.  Comparative study of systemic interferon alfa-nl and isotretinoin in the treatment of resistant condylomata acuminata.

Authors:  E A Olsen; F F Kelly; R T Vollmer; D A Buddin; P K Weck
Journal:  J Am Acad Dermatol       Date:  1989-06       Impact factor: 11.527

8.  Management of psoriasis: the position of retinoid drugs.

Authors:  A Arechalde; J H Saurat
Journal:  BioDrugs       Date:  2000-05       Impact factor: 5.807

9.  13-cis-Retinoic acid in rosacea. Clinical and laboratory findings.

Authors:  J B Schmidt; W Gebhart; M Raff; J Spona
Journal:  Acta Derm Venereol       Date:  1984       Impact factor: 4.437

10.  Comparative study of systemic interferon alfa-2a plus isotretinoin versus isotretinoin in the treatment of recurrent condyloma acuminatum in men.

Authors:  E Cardamakis; I G Kotoulas; K Relakis; K Metalinos; J Michopoulos; E Stathopoulos; H Mantouvalos
Journal:  Urology       Date:  1995-05       Impact factor: 2.649

View more
  12 in total

Review 1.  Rosacea: new and emerging treatments.

Authors:  Farah A Moustafa; Laura F Sandoval; Steven R Feldman
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

Review 2.  Updated Physician's Guide to the Off-label Uses of Oral Isotretinoin.

Authors:  Steven Brandon Nickle; Nathan Peterson; Michael Peterson
Journal:  J Clin Aesthet Dermatol       Date:  2014-04

3.  Oral Isotretinoin May Improve the Symptoms of Chronic Rhinosinusitis.

Authors:  Habibullah Aktaş; Can Ergin; Aziz Tunç; Süha Ertuğrul
Journal:  J Clin Diagn Res       Date:  2017-05-01

Review 4.  Rosacea Management.

Authors:  Manal Abokwidir; Steven R Feldman
Journal:  Skin Appendage Disord       Date:  2016-05-18

5.  Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2012-03

6.  [Systemic therapy of rosacea].

Authors:  M Schaller; K Belge
Journal:  Hautarzt       Date:  2013-07       Impact factor: 0.751

Review 7.  [Pathogenesis, clinical picture, and current therapy of rosacea].

Authors:  L I Gonser; C E Gonser; M Schaller
Journal:  Hautarzt       Date:  2016-01       Impact factor: 0.751

8.  Multi-drugs resistant acne rosacea in a child affected by Ataxia-Telangiectasia: successful treatment with Isotretinoin.

Authors:  Nicoletta Cantarutti; Alessia Claps; Giulia Angelino; Luciana Chessa; Francesco Callea; May El Hachem; Andrea Diociaiuti; Andrea Finocchi
Journal:  Ital J Pediatr       Date:  2015-03-28       Impact factor: 2.638

9.  Update on the management of rosacea.

Authors:  Allison P Weinkle; Vladyslava Doktor; Jason Emer
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-04-07

10.  Combination of new multifunctional molecules for erythematotelangiectatic rosacea disorder.

Authors:  Hanane Chajra; Mahdi Nadim; Daniel Auriol; Kuno Schweikert; Fabrice Lefevre
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.